Fundamental Analysis
61 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +67.7% | +14.2% | 2 / 3 | +32.5% | +3.05 pp | +1.56 pp | +12.4% | 0.98 | 4.04 | 1.576 | +32,5% | 117 | +67,7% | 4.04 | 4.79 | −15,6% |
| Pts | 12 | 0 | 8 | 12 | 12 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 72.800 (close price on 2026-10-19)EPS (TTM): 18.011
Financial charts
1.Revenue & growth
VND bn1.576Q2/26
1.Revenue & growth
VND bn1.576Q2/26
2.Profit & growth
VND bn117Q2/26
3.Profit mix (Penman)
VND bn485Q2/26
4.Margins & cost structure
%24.3%Q2/26
5.Returns & cash cycle
% · days11.1%Q2/26
6.Earnings quality & cash
VND bn1.567Q2/26
7.Asset structure
VND bn9.326Q2/26
8.Funding & debt health
VND bn · times9.326Q2/26
9.Revenue backlog
VND bn45,5Q2/26
10.Valuation
times · %4,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %4.973Q2/26
Adjusted EPS growth, latest quarter
67.7%
Average adjusted EPS growth, 3 quarters
14.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26